William Blalock

Dr. William Blalock

National Research Council - CNR
+1
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Leukemia
Verified
Journal Article
Open access
PDF file
FCF Chang
F Chang
JLJ T Lee
J T Lee
PNP M Navolanic
P M Navolanic
LSL S Steelman
L S Steelman
JSJ G Shelton
J G Shelton
JMJames A. McCubrey
James A. McCubrey
The PI3K/Akt signal transduction cascade has been investigated extensively for its roles in oncogenic transformation. Initial studies implicated both PI3K and Akt in prevention of apoptosis. However, more recent evidence has also associated this pathway with regulation of cell cycle progression. Uncovering the signaling network spanning from extracellular environment to the nucleus should illuminate biochemical events contributing to malignant transformation. Here, we discuss PI3K/Akt-mediated signal transduction including its mechanisms of activation, signal transducing molecules, and effects on gene expression that contribute to tumorigenesis. Effects of PI3K/Akt signaling on important proteins controlling cellular proliferation are emphasized. These targets include cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors. Furthermore, strategies used to inhibit the PI3K/Akt pathway are presented. The potential for cancer treatment with agents inhibiting this pathway is also addressed.

20 June 2003 in Leukemia
Verified
Journal Article
Closed access
FCF Chang
F Chang
LSL S Steelman
L S Steelman
JLJ T Lee
J T Lee
JSJ G Shelton
J G Shelton
PNP M Navolanic
P M Navolanic
JMJames A. McCubrey
James A. McCubrey

21 April 2015 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
ABAlberto Bavelloni
Alberto Bavelloni
MPManuela Piazzi
Manuela Piazzi
MRMirco Raffini
Mirco Raffini
IFIrene Faenza
Irene Faenza
WBWilliam Blalock
William Blalock

3 December 2017 in Anticancer Research
Verified
Journal Article
Open access
PDF file
ABAlberto Bavelloni
Alberto Bavelloni
GRGiulia Ramazzotti
Giulia Ramazzotti
Alessandro PoliAlessandro Poli
Alessandro Poli
MPManuela Piazzi
Manuela Piazzi
EFEnrico Focaccia
Enrico Focaccia
Irene FaenzaIrene Faenza
Irene Faenza
MicroRNAs (miRNAs) are a group of highly conserved small non-coding RNAs that were found to enhance mRNA degradation or inhibit post-transcriptional translation. Accumulating evidence indicates that miRNAs contribute to tumorigenesis and cancer metastasis. microRNA-210 has been largely studied in the past several years and has been identified as a major miRNA induced under hypoxia. A variety of miR-210 targets have been identified pointing to its role, not only in mitochondrial metabolism, but also in angiogenesis, the DNA damage response, cell proliferation, and apoptosis. Based on earlier research findings, this review aims to provide a current overview on the involvement of miRNA-210 in biological processes and diseases.

12 February 2010 in Eye
Verified
Journal Article
Closed access
PDF file
PVPiera Versura
Piera Versura
PNPaolo Nanni
Paolo Nanni
ABAlberto Bavelloni
Alberto Bavelloni
WBWilliam Blalock
William Blalock
MPManuela Piazzi
Manuela Piazzi
ECE C Campos
E C Campos

1 March 2003
Verified
Journal Article
Closed access
FCFumin Chang
Fumin Chang
LSLinda S Steelman
Linda S Steelman
JSJohn G Shelton
John G Shelton
JLJohn T Lee
John T Lee
PNPatrick M Navolanic
Patrick M Navolanic
JMJames A. McCubrey
James A. McCubrey